Loading
SH
Signify Health, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 09 May 2022.
Signify Health, Inc.: what insiders have been doing
This page follows insider dealings at Signify Health, Inc. as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. No insider at Signify Health, Inc. has published a filing in the past twelve months. The most recent one dates from 29 March 2023.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
77
Thresholds
n/a
Buy Volume
€601,570
6 ops. · all time
Sell Volume
n/a
8 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$693.5M
Net income-US$496.6M-71.6% margin
Last declaration on 29 March 2023
Declarations77 total
14,672 sharesClass A Common StockSEC:0000899243-23-009941:0
14,672 sharesClass A Common StockSEC:0000899243-23-009919:0
506,975 sharesClass A Common StockSEC:0000899243-23-009939:0
1,260,850 sharesClass A Common StockSEC:0000899243-23-009921:0
145,011 sharesClass A Common StockSEC:0000899243-23-009948:0
14,672 sharesClass A Common StockSEC:0000899243-23-009942:0
120,837 sharesClass A Common StockSEC:0000899243-23-009945:0
3,686,599 sharesClass A Common StockSEC:0000899243-23-009946:0
24,173 sharesClass A Common StockSEC:0000899243-23-009934:0
772,875 sharesClass A Common StockSEC:0000899243-23-009935:0
14,672 sharesClass A Common StockSEC:0000899243-23-009928:0
24,173 sharesClass A Common StockSEC:0000899243-23-009936:0
14,672 sharesClass A Common StockSEC:0000899243-23-009924:0
24,994 sharesClass A Common StockSEC:0000899243-23-009930:0
188,576 sharesClass A Common StockSEC:0000899243-23-009929:0
1,030,500 sharesClass A Common StockSEC:0000899243-23-009917:0
24,173 sharesClass A Common StockSEC:0000899243-23-009914:0
237,269 sharesClass A Common StockSEC:0000899243-23-009923:0
3,821 shares@ US$28.37100.0% of flowClass A Common StockSEC:0000950103-23-003900:0
5,660 shares@ US$28.3724.0% of flowClass A Common StockSEC:0000950103-23-003898:0
6,564 shares@ US$28.37100.0% of flowClass A Common StockSEC:0000950103-23-003902:0
3,750 shares@ US$28.37100.0% of flowClass A Common StockSEC:0000950103-23-003901:0
1,160 shares@ US$28.37100.0% of flowClass A Common StockSEC:0000950103-23-003899:0
2,736 shares@ US$28.37100.0% of flowClass A Common StockSEC:0000950103-23-003904:0
6,369 shares@ US$28.3764.6% of flowClass A Common StockSEC:0000950103-23-003905:0
25 of 77 declarations
About Signify Health, Inc.
Signify Health, Inc. is a U.S.-based healthcare services company focused on value-based care and home-centered clinical engagement. Historically listed on the NYSE under ticker SGFY in the United States, Signify built its business around a combination of analytics, proprietary technology, and a nationwide provider network designed to improve care coordination, identify health risks earlier, and help payers and providers manage population health more effectively. The company is headquartered in Dallas, Texas, and for much of its independent life it operated with additional operational hubs in places such as Norwalk, New York, and Rapid City. From a corporate-history standpoint, Signify was formed through a series of healthcare platform combinations and acquisitions, including businesses tied to episodic care and in-home assessments, before ultimately being acquired by CVS Health; that transaction was completed in March 2023.
Operationally, Signify’s core value proposition centered on in-home health evaluations. These are clinician-led visits performed in a member’s home to gather clinical information, review medications, screen for chronic conditions, and identify social and behavioral health needs that may not surface during standard office visits. The company also offered diagnostic and preventive services, plus care-coordination pathways intended to route patients to the next best action after the home visit. In practical terms, the model aimed to close information gaps between primary care encounters, strengthen risk stratification, and support better downstream utilization management for health plans and provider organizations.
Read moreShow less
From a competitive perspective, Signify Health occupied a niche at the intersection of home-based care, population health, and value-based reimbursement. Its addressable market reflected several long-term U.S. healthcare trends: an aging population, growing demand for care delivered outside hospitals, payer pressure to improve outcomes while controlling costs, and a broader shift toward risk-based contracts. That positioning gave Signify a relevant role with health plans, health systems, physician groups, and employers looking for scalable ways to improve engagement and identify unmet care needs. The company’s nationwide clinician network and home-visit infrastructure were key differentiators versus more traditional care-management models.
A major recent milestone was CVS Health’s acquisition, first announced in 2022 and completed on March 29, 2023, for roughly $7.8 billion to $8 billion. As a result, Signify Health is no longer an independent public company, but its operating model remains important for understanding the strategic logic of CVS’s healthcare-services expansion and the broader shift toward care delivery in the home. For French-speaking investors, SGFY is best viewed as a case study in how technology-enabled home health platforms can become strategic assets in the U.S. healthcare market.
